Metastatic signals

Lindau protein

Written byTudor Toma
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Malignant cells are thought to metastasize into specific organs as a result of interactions between cancer cell chemokine receptors and matching chemokines in target organs, but the mechanisms involved in reprogramming a tumor cell to express new chemokine receptors have been unclear. In the September 18 Nature, Peter Staller and colleagues at the Friedrich Miescher Institute show that the chemokine receptor CXCR4 gene is downregulated by von Hippel–Lindau tumor suppressor protein (pVHL) and may have a role in causing tumor cells to migrate and home in on a specific set of organs (Nature, 425:307-311, September 18, 2003).

Staller et al. introduced VHL into renal carcinoma cells (which lack a normal copy of this gene) to search for genes that are regulated by pVHL. Using DNA microarray analysis, they observed that normal pVHL dramatically reduced the production of the receptor protein CXCR4, an affect that was associated with poor tumor-specific survival. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies